Microbot Medical Inc. (MBOT) Form 10-Q — May 13, 2026
Microbot Medical Inc. reported revenues of $105,000 for the three months ended March 31, 2026, marking the company's first revenue recognition. This is a significant milestone for the company, which has not previously recognized any revenues. The company's net loss for the quarter was $3,671,000, an increase of 41.1% from the net loss of $2,601,000 in the same period of 2025.
Key figures
- Eps Beat
- -
- Revenue
- 105
- Total Debt
- 574
- Revenue Yoy
- -
- Cash Position
- 3657
- Shares Outstanding
- 67158044
- Net Loss Growth
- 41.1% (from $2,601 to $3,671)
- Revenue Growth
- 105% (from $0 to $105)
Price after filing
1 day: -14.7%7 days: -19.8%30 days: -16.1%
Close on the filing date to close N calendar days later (from $2.17). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.